Reacción #2243

ord-ff129fa8213d45ca8f4648e29b01c951

Reactivos

Ninguno

Disolventes

Condiciones de reacción

Condiciones detalladas
See reaction.notes.procedure_details.

Tratamiento posterior

  1. 1
    FiltraciónThe mixture was filtered through celite
  2. 2
    Otropartitioned between dichloromethane and brine
  3. 3
    Secadothe organic extracts were dried over anhydrous magnesium sulfate
  4. 4
    Otrothe resulting crude material was purified by prep TLC

Procedimiento

To a solution of rapamycin (5 mg, 0.055 mmol) in dichloromethane (0.1 mL) was added water (0.02 mL) followed by DDQ (2.4 mg, 0.011 mmol), and the resulting dark brown suspension was stirred at room temperature for 45 min. The mixture was filtered through celite and then partitioned between dichloromethane and brine; the organic extracts were dried over anhydrous magnesium sulfate and the resulting crude material was purified by prep TLC. The desired product was isolated as a colorless oil (1.2 mg). 1 H NMR (CDCl3, 400 MHz, 3:1 mixture of trans:cis amide rotamers; data for the trans-rotamer): -- 7.145 (d, J=10.4 Hz, 1H), 6.635 (dd, J=14.9, 10.6 Hz, 1H), 6.57-6.48 (m, 2H), 6.224 (dd, J=15.1, 10.6 Hz, 1H), 5.662 (dd, J=15.1, 8.6 Hz, 1H), 5.447 (d, J=11.2 Hz, 1H), 4.305 (br d, J=5.4 Hz, 1H), 3.983 (d, J=5.4 Hz, 1H), 3.385 (s, 3H), 3.346 (s, 3H),; MS (ESl+/NH4OAc) m/z 920 (M+Na+), 915 (M+NH4+), 898, 880; UV (MeOH) max 318 nm.

Fuente

DOI: 10.6084/m9.figshare.5104873.v1Patente: US05728710uspto-grants-1998_03